Adam Rivadeneyra, MD, a sports medicine specialist with Irvine, Calif.-based Hoag Orthopedic Institute, spoke to Becker's Spine Review about his predictions for the field of biologics.
Biologics
NanoFuse Biologics expanded into Asia after the successful use of its technology in a patient suffering from degenerative spine disease and osteoporosis in Thailand.
Biotechnology company DiscGenics treated the first Utahns in its nationwide clinical study of injectable disc cell therapy for degenerative disc disease.
The California Institute for Regenerative Medicine could close after awarding all allocated funds, The Scientist reports.
A federal court ordered that Sunrise, Fla.-based regenerative medicine companies US Stem Cell Clinic and US Stem Cell stop providing stem cell treatments to patients, according to the U.S. Department of Justice.
Advertisement
NervGen Pharma will use its developing drug technology for spinal cord injuries in a new multiple sclerosis program.
Biologics therapies have the promise to revolutionize orthopedics and sports medicine, but unauthorized operators pose a serious threat to emerging therapies.
Orthobiologics company Cerapedics appointed Patrick O'Connor to serve as vice president of clinical and market development.
Chinese biologics technology company WuXi Biologics is expanding its conjugation solution center to include commercial manufacturing later this year.
AlloSource partnered with Manufacturing USA in a new public-private initiative, the Advanced Regenerative Manufacturing Institute.